桥梁自和内分泌体功能障碍:桥梁整合体1在阿尔茨海默氏病中的作用
Julia Duckhorn1, Doo Kyung Kim, Yu-Wen Alvin Huang
1Department of Molecular Biology, Cell Biology and Biochemistry, Center for Translational Neuroscience, Carney Institute for Brain Science and Brown Institute for Translational Science, Brown University, Providence, RI, USA.
Neural regeneration research
|August 14, 2025
概括
桥梁整合器1 (BIN1) 是阿尔茨海默病的一个关键遗传风险因素. 干扰BIN1功能会损害细胞清除,导致神经退行和有毒蛋白质聚合物的形成.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 阿尔茨海默病 (AD) 是导致痴呆的主要原因,治疗选择有限.
- 自和内分泌体通路对于细胞废物清除至关重要.
- 错误折叠的蛋白质,如粉样β和,在AD大脑中积累.
研究的目的:
- 审查自和内分泌体通路在AD病变发生过程中的作用.
- 要突出桥梁整合器1 (BIN1) 作为AD中一个核心的遗传风险因素.
- 探索BIN1对细胞清除和AD病理学的影响.
主要方法:
- 在AD中对BIN1,自和内分泌体通路的最近研究的文献综述.
- 分析了将BIN1变化与AD相关的蛋白质聚合联系在一起的研究.
- 对BIN1对突触功能和神经炎症的影响的综合发现.
主要成果:
- BIN1是阿尔茨海默病的重要遗传风险因素.
- 改变的BIN1表达和异型与增加的病理和粉样β处理相关.
- BIN1影响神经炎症,突触传播和细胞平衡.
结论:
- 在BIN1介导的细胞清除中出现的障碍,有助于阿尔茨海默病的进展.
- 准BIN1为增强AD细胞清除机制提供了潜在的治疗策略.
- 对BIN1多方面的作用进行进一步的研究可能会导致新的AD干预措施.
相关概念视频
Delivery Pathways to the Lysosome
7.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
7.2K
Autophagy
4.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Alzheimer's Disease: Overview
668
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
668
Autophagic Cell Death
3.6K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
Alzheimer's Disease: Treatment
261
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
261


